Key terms

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MRNA news

Apr 15 5:48am ET Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push by TipRanks Apr 12 11:08am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 11 11:59am ET Moderna (NASDAQ:MRNA) Postpones Plans of Vaccine Plant in Kenya by TipRanks Apr 11 6:34am ET Moderna pauses efforts to build vaccine plant in Kenya, FT says by TipRanks Apr 09 1:32pm ET Moderna’s (NASDAQ:MRNA) Latest Treatment Line Gives Shares New Life by TipRanks Apr 09 8:10am ET Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA) by TipRanks Apr 09 7:13am ET Analysts Are Bullish on These Healthcare Stocks: Inozyme Pharma (INZY), Moderna (MRNA) by TipRanks Apr 08 11:00pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Apr 08 2:43pm ET Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential by TipRanks Apr 04 8:38am ET Arbutus ‘pleased’ with claim construction ruling in patent infringement suit by TipRanks Apr 03 3:05pm ET Moderna could owe $1B-$3B in royalties, says Jefferies by TipRanks Apr 03 2:02pm ET Roivant, Arbutus higher after ruling on COVID patent order by TipRanks Apr 03 1:56pm ET Jefferies sees Roivant rallying 5%-10% on today’s COVID patent order by TipRanks Apr 03 11:07am ET Moderna announces publication of Phase 1/2 interim data on mRNA-3927 by TipRanks Apr 02 8:10am ET Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Moderna (MRNA) by TipRanks Mar 29 3:07am ET Maintaining Sell Rating on Moderna Amid Financial Strains and Competitive Pressures by TipRanks Mar 28 8:00am ET Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT) by TipRanks Mar 28 7:55am ET Buy Rating Affirmed for Moderna Amid Strategic Partnerships and Promising Vaccine Pipeline by TipRanks Mar 28 7:05am ET Balancing Scientific Progress with Market Realities: Moderna’s Hold Rating Explained by TipRanks Mar 28 7:00am ET Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA) by TipRanks Mar 28 6:35am ET RBC Capital Sticks to Its Buy Rating for Moderna (MRNA) by TipRanks Mar 28 5:55am ET Moderna’s Promising Vaccine Pipeline Balanced with Near-Term Caution: Hold Rating Maintained by TipRanks Mar 28 5:01am ET Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR) by TipRanks Mar 27 8:45am ET Moderna to host investor event by TipRanks Mar 27 6:39am ET Moderna advances multiple vaccine programs to clinical trials by TipRanks Mar 27 6:37am ET Blackstone to provide up to $750M to fund Moderna’s influenza program by TipRanks Mar 27 5:55am ET Moderna to host investor event by TipRanks Mar 26 5:19pm ET Moderna to host investor event by TipRanks Mar 26 10:41am ET Moderna’s Next-Gen COVID Vaccine Triumphs in Trial by TipRanks Mar 25 9:56am ET Early notable gainers among liquid option names on March 25th by TipRanks Mar 19 8:11am ET Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE) by TipRanks
Yesterday 7:00am ET Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 by Accesswire Apr 03 11:00am ET Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature by Accesswire Mar 27 6:30am ET Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials by Accesswire Mar 26 7:00am ET Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine by Accesswire

MRNA Financials

1-year income & revenue

Key terms

MRNA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MRNA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching